21Shares Refines Injective ETF Plans: Nasdaq Listing, FTSE Index, 40–60% Staking
- —21Shares filed an updated Injective ETF application with the SEC almost a year after its first filing
- —The fund plans to list on Nasdaq and switch its benchmark from CME CF to the FTSE Injective Index
- —Coinbase Custody and BitGo Bank & Trust will serve as custodians; baskets set at 10,000 shares
- —The ETF intends to stake 40–60% of its INJ holdings, with a 21-day unbonding period for rewards
Why it matters: An ETF would broaden institutional access to INJ, a token with a market cap under $800 million, though approval timing remains unclear.
Source: BTC-ECHO